This product is for research use only and is not for human consumption or therapeutic use.
Purity:
98
Molecular Formula:
C19H17D8BN4O4
Molecular Weight:
392.29
Alternative Names:
PS-341-d8; LDP-341-d8; NSC 681239-d8
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Bortezomib-d8 is the deuterium labeled Bortezomib. Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is the first proteasome inhibitor anticancer agent. Anti-cancer activity[1][2].
Storage Temperature:
-20°C (Powder, stored under nitrogen)